Wisconsin Soybean Marketing Board Opens Requests for Proposals

Apr 11, 2023

The Wisconsin Soybean Marketing Board (WSMB) is now accepting research requests for proposals (RFP) for fiscal year 2024. To submit a proposal, email the proposal cover sheet, full project proposal and a budget template to admin@wisoy.org no later than 5 p.m. CST on May 15, 2023.

The aim of this RFP is to generate both new vendor relationships and viable project/campaign opportunities. WSMB is seeking projects in the following core research areas:

Market expansion of commodity soybeans and soybean meal into both new and existing overseas markets;
Promotion of Wisconsin ports and other facilities available for exporting bulk soybeans;
Promotion of Wisconsin’s growing identity preserved soybean sector;
Promotion of Wisconsin’s biodiesel/renewable diesel use;
Market assessment of the current and potential use of soy-based products by state and federal fleets, cities and municipalities, private companies, fleets, consumer and farmers;
And assess and identify ways to expand soybean protein use in the animal feeds market.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.